Vincerx Pharma, Inc.
VINC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$30,074 | -$40,157 | -$65,367 | -$39,306 |
| Dep. & Amort. | $1,090 | $915 | $939 | $340 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $3,473 | $3,563 | $10,056 | $23,313 |
| Change in WC | -$178 | -$4,191 | -$1,020 | $5,609 |
| Other Non-Cash | -$438 | -$583 | -$4,212 | -$23,358 |
| Operating Cash Flow | -$26,127 | -$40,453 | -$59,604 | -$33,402 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$5,258 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$11,463 | -$11,821 | -$42,978 | $0 |
| Inv. Sales/Matur. | $11,675 | $53,321 | $2,400 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $212 | $41,500 | -$40,578 | -$5,258 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $17,874 | $114 | $280 | $47,431 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $118 | $114 | $280 | $41,022 |
| Financing Cash Flow | $17,992 | $114 | $280 | $88,453 |
| Forex Effect | $135 | -$40 | $71 | -$21 |
| Net Chg. in Cash | -$7,788 | $1,121 | -$99,831 | $49,772 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $12,854 | $11,733 | $111,564 | $61,792 |
| End Cash | $5,066 | $12,854 | $11,733 | $111,564 |
| Free Cash Flow | -$26,127 | -$40,453 | -$59,604 | -$38,660 |